URETHRAL CANCER
Clinical trials for URETHRAL CANCER explained in plain language.
Never miss a new study
Get alerted when new URETHRAL CANCER trials appear
Sign up with your email to follow new studies for URETHRAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat cancers: enhertu studied in 20+ tumor types
Disease control Recruiting nowThis study is testing the drug T-DXd (Enhertu) in 100 adults with advanced HER2-positive solid tumors who have already tried other treatments and have no good options left. The goal is to see how well the drug works in real-world settings, including how many patients respond and …
Matched conditions: URETHRAL CANCER
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New imaging agent could reveal which cancers respond to immunotherapy
Diagnosis Recruiting nowThis phase I/II trial tests a radioactive tracer called 64Cu-GRIP B, which targets granzyme B—a substance released by immune cells. By using PET scans, researchers hope to see immune activity in tumors and predict whether immunotherapy will work. The study involves about 91 adult…
Matched conditions: URETHRAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Rahul Aggarwal • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
Massive cancer database aims to unlock secrets of the disease
Knowledge-focused Recruiting nowThis study is building a huge registry of information and biological samples from adults with or at risk for many types of cancer, as well as healthy volunteers. Researchers will use this resource to study what causes cancer and how to better prevent, detect, and treat it. The re…
Matched conditions: URETHRAL CANCER
Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC